Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$33.11 - $55.01 $951,415 - $1.58 Million
-28,735 Closed
0 $0
Q3 2021

Nov 17, 2021

BUY
$50.07 - $66.05 $6,108 - $8,058
122 Added 0.43%
28,735 $1.44 Million
Q2 2021

Aug 18, 2021

BUY
$56.61 - $80.46 $23,379 - $33,229
413 Added 1.46%
28,613 $1.8 Million
Q1 2021

May 21, 2021

BUY
$86.23 - $125.19 $168,148 - $244,120
1,950 Added 7.43%
28,200 $2.62 Million
Q4 2020

Feb 16, 2021

BUY
$79.17 - $111.47 $373,207 - $525,469
4,714 Added 21.89%
26,250 $2.35 Million
Q3 2020

Nov 17, 2020

SELL
$81.91 - $134.94 $472,866 - $779,008
-5,773 Reduced 21.14%
21,536 $2.23 Million
Q2 2020

Aug 13, 2020

SELL
$54.33 - $89.52 $27,110 - $44,670
-499 Reduced 1.79%
27,309 $2.16 Million
Q1 2020

May 18, 2020

SELL
$49.34 - $68.76 $76,970 - $107,265
-1,560 Reduced 5.31%
27,808 $1.61 Million
Q4 2019

Feb 18, 2020

SELL
$51.21 - $59.06 $21,764 - $25,100
-425 Reduced 1.43%
29,368 $1.58 Million
Q3 2019

Nov 26, 2019

SELL
$40.6 - $57.2 $3,938 - $5,548
-97 Reduced 0.32%
29,793 $1.56 Million
Q2 2019

Aug 19, 2019

BUY
$39.92 - $53.86 $2,594 - $3,500
65 Added 0.22%
29,890 $1.44 Million
Q1 2019

May 15, 2019

SELL
$48.23 - $66.16 $86,090 - $118,095
-1,785 Reduced 5.65%
29,825 $1.51 Million
Q4 2018

Feb 15, 2019

SELL
$55.63 - $73.24 $49,788 - $65,549
-895 Reduced 2.75%
31,610 $1.87 Million
Q3 2018

Nov 14, 2018

SELL
$52.05 - $66.51 $13,689 - $17,492
-263 Reduced 0.8%
32,505 $2.14 Million
Q2 2018

Aug 15, 2018

SELL
$48.33 - $55.64 $3,141 - $3,616
-65 Reduced 0.2%
32,768 $1.65 Million
Q1 2018

May 15, 2018

BUY
$44.44 - $54.39 $42,218 - $51,670
950 Added 2.98%
32,833 $1.73 Million
Q4 2017

Feb 14, 2018

BUY
$37.77 - $47.75 $1.2 Million - $1.52 Million
31,883
31,883 $1.48 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $473M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Colony Group LLC Portfolio

Follow Colony Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Group LLC with notifications on news.